Skip to content

BIOREGENX, INC.

BRGX

CIK 0001593184

← back to feed
Revenue (TTM)
$1.9M
−20.8% YoY Q1 May 2026
Net Income (TTM)
−$552.18K
+93.3% YoY Q1 May 2026
EPS Diluted (TTM)
$0.00
+100.0% YoY Q1 May 2026
Gross Margin
80.9%
Q1 May 2026
Operating Margin
-18.9%
Q1 May 2026
Net Margin
-29.1%
Q1 May 2026
Free Cash Flow (TTM)
−$385.78K
Q1 May 2026
Cash
$83.63K
Q1 May 2026
Total Debt
$1.19M
Q1 May 2026
Shares Outstanding
971.58M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings